Search Results

Search Results for "depuy"

• Hip joints under investigation are among many recalls
  A story in the Minneapolis Star Tribune notes that Johnson & Johnson’s hip joints, currently the basis of an investigation by federal prosecutors, were part of a string of 30 recalls by the company over the past three-and-a-half years. Johnson & Johnson revealed the government investigatio...

• Mesh verdict the first of 4,000 cases
  According to a story in the Philadelphia Inquirer, a woman awarded $3.35 million in a case against Johnson & Johnson over the company’s vaginal mesh implant represents the first trial of 1,200 similar lawsuits in New Jersey – where Johnson & Johnson is based. But the total number of laws...

• J&J recalls another metal hip component
  Johnson & Johnson has recalled a metal hip component sold outside the United States, called Adept modular heads, Reuters reports. The company is already facing about 10,000 lawsuits connected to another model of all-metal hip implant called the ASR, which was recalled in 2010 over its tendency t...

• J&J suppressed warnings about hip implant
  A story in U.K. newspaper The Telegraph says Johnson & Johnson employees were not only aware of problems with its ASR hip implant for years before the device’s 2010 recall, but actively discussed manipulating data to conceal those problems. Studies show that nearly half of the implants, made b...

• Editorial: Hip implant maker has ‘explaining to do’
  An editorial in the New York Times takes Johnson & Johnson subsidiary DePuy Orthopaedics to task for apparently sitting on evidence that a line of its hip implants posed a danger to patients. “Though the company says the evidence will ultimately show that it acted appropriately, it clearly has...

• Expert: Hip implants had design flaws
  During a trial centering on Johnson & Johnson’s ASR hip implants, Bloomberg reports, a biomedical engineering expert told the jury that the devices had multiple design flaws. Johnson & Johnson recalled the all-metal implants, manufactured by subsidiary DePuy Orthopaedics, in 2010. At the t...

• Senators seek to ban ‘pay for delay’
  In a bipartisan effort, U.S. Senators have reintroduced legislation banning a pharmaceutical industry practice that keeps lower-cost medications away from patients who need them. The practice, commonly called “pay for delay,” occurs when one drug company pays another to delay introducing a less-...

• Expert says hip implant was ‘toxic’
  In a Los Angeles Superior Court trial, an occupational medicine specialist testified that a man’s artificial hip had to be removed because of “toxic exposure” from metal debris that the implant was shedding, according to a Reuters story. Plaintiff Loren Kransky’s is the first of more than 10...

• J&J accused of suppressing generic competitor
  European regulators are accusing Johnson & Johnson of illegally paying another company to delay the availability of a generic version of a product – in the process denying cancer patients access to a less expensive source of a drug that eases severe pain. According to a story in the New York T...

• J&J executive knew of hip implant problems
  Johnson & Johnson appointed Andrew Ekdahl to head its orthopaedics division in 2011, a year after the company recalled its ASR artificial hip joints following thousands of complaints that they caused debilitating injuries. According to the New York Times, the company had billed Ekdahl’s appoin...